NAD attenuates oxidative DNA damages induced by amyloid beta-peptide in primary rat cortical neurons

References

• O’Brien RJ, Wong PC. Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci 2011;34: 185–204.
   PubMed Web of Science ®Google Scholar
• Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 1994;77: 817–827.
   PubMed Web of Science ®Google Scholar
• Santos RX, Correia SC, Zhu X, Lee HG, Petersen RB, Nunomura A, et al. Nuclear and mitochondrial DNA oxidation in Alzheimer's disease. Free Radic Res 2012;46:565–576.
   PubMed Web of Science ®Google Scholar
• Lovell MA, Gabbita SP, Markesbery WR. Increased DNA oxidation and decreased levels of repair products in Alzheimer's disease ventricular CSF. J Neurochem 1999;72: 771–776.
   PubMed Web of Science ®Google Scholar
• Lovell MA, Soman S, Bradley MA. Oxidatively modified nucleic acids in preclinical Alzheimer's disease (PCAD) brain. Mech Ageing Dev 2011;132:443–448.
   PubMed Web of Science ®Google Scholar
• Wang J, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment. J Neurochem 2006;96:825–832.
   PubMed Web of Science ®Google Scholar
• Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J Neurochem 2005;93:953–962.
   PubMed Web of Science ®Google Scholar
• Ying W. NAD+ and NADH in cellular functions and cell death. Front Biosci 2006;11:3129–3148.
   PubMed Web of Science ®Google Scholar
• Ying W. NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences. Antioxid Redox Signal 2008;10:179–206.
   PubMed Web of Science ®Google Scholar
• Abeti R, Duchen MR. Activation of PARP by oxidative stress induced by beta-amyloid: implications for Alzheimer's disease. Neurochem Res 2012;37:2589–2596.
   PubMed Web of Science ®Google Scholar
• Qin W, Yang T, Ho L, Zhao Z, Wang J, Chen L, et al. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 2006;281:21745–21754.
   PubMed Web of Science ®Google Scholar
• Chen SD, Wu CL, Lin TK, Chuang YC, Yang DI. Renin inhibitor aliskiren exerts neuroprotection against amyloid beta-peptide toxicity in rat cortical neurons. Neurochem Int 2012;61:369–377.
   PubMed Web of Science ®Google Scholar
• Wu CL, Yin JH, Hwang CS, Chen SD, Yang DY, Yang DI. c-Jun-dependent sulfiredoxin induction mediates BDNF protection against mitochondrial inhibition in rat cortical neurons. Neurobiol Dis 2012;46:450–462.
   PubMedGoogle Scholar
• Wu CL, Hwang CS, Yang DI. Protective effects of brain-derived neurotrophic factor against neurotoxicity of 3-nitropropionic acid in rat cortical neurons. Neurotoxicology 2009;30:718–726.
   PubMedGoogle Scholar
• Wu CL, Chen SD, Yin JH, Hwang CS, Yang DI. Erythropoietin and sonic hedgehog mediate the neuroprotective effects of brain-derived neurotrophic factor against mitochondrial inhibition. Neurobiol Dis 2010;40:146–154.
   PubMedGoogle Scholar
• Chen J, Jin K, Chen M, Pei W, Kawaguchi K, Greenberg DA, Simon RP. Early detection of DNA strand breaks in the brain after transient focal ischemia: implications for the role of DNA damage in apoptosis and neuronal cell death. J Neurochem 1997;69:232–245.
   PubMed Web of Science ®Google Scholar
• Tang CM, Hwang CS, Chen SD, Yang DI. Neuroprotective mechanisms of minocycline against sphingomyelinase/ceramide toxicity: roles of Bcl-2 and thioredoxin. Free Radic Biol Med 2011;50:710–721.
   PubMed Web of Science ®Google Scholar
• Ju TC, Yang YT, Yang DI. Protective effects of S-nitrosoglutathione against neurotoxicity of 3-nitropropionic acid in rat. Neurosci Lett 2004;362:226–231.
   PubMedGoogle Scholar
• Moreira PI, Nunomura A, Nakamura M, Takeda A, Shenk JC, Aliev G, et al. Nucleic acid oxidation in Alzheimer disease. Free Radic Biol Med 2008;44:1493–1505.
   PubMedGoogle Scholar
• Kasai H, Nishimura S. Hydroxylation of deoxyguanosine at the C-8 position by ascorbic acid and other reducing agents. Nucleic Acids Res 1984;12:2137–2145.
   PubMed Web of Science ®Google Scholar
• Dizdaroglu M. Base-excision repair of oxidative DNA damage by DNA glycosylases. Mutat Res 2005;591:45–59.
   PubMed Web of Science ®Google Scholar
• Clark RSB, Chen M, Kochanek PM, Watkins SC, Jin KL, Draviam R, et al. Detection of single- and double-strand DNA breaks after traumatic brain injury in rats: comparison of in situ labeling techniques using DNA polymerase I, the Klenow fragment of DNA polymerase I, and terminal deoxynucleotidyl transferase. J Neurotrauma 2001;18:675–689.
   PubMed Web of Science ®Google Scholar
• Garcia-Alloza M, Robbins EM, Zhang-Nunes SX, Purcell SM, Betensky RA, Raju S, et al. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis 2006;24:516–524.
   PubMed Web of Science ®Google Scholar
• Wang S, Xing Z, Vosler PS, Yin H, Li W, Zhang F, et al. Cellular NAD replenishment confers marked neuroprotection against ischemic cell death: role of enhanced DNA repair. Stroke 2008;39:2587–2595.
   PubMed Web of Science ®Google Scholar
• Wang J, Zhai Q, Chen Y, Lin E, Gu W, McBurney MW, He Z. A local mechanism mediates NAD-dependent protection of axon degeneration. J Cell Biol 2005;170:349–355.
   PubMed Web of Science ®Google Scholar
• Pittelli M, Felici R, Pitozzi V, Giovannelli L, Bigagli E, Cialdai F, et al. Pharmacological effects of exogenous NAD on mitochondrial bioenergetics, DNA repair, and apoptosis. Mol Pharmacol 2011;80:1136–1146.
   PubMed Web of Science ®Google Scholar
• Kim TK, Lee JE, Park SK, Lee KW, Seo JS, Im JY, et al. Analysis of differential plaque depositions in the brains of Tg2576 and Tg-APPswe/PS1dE9 transgenic mouse models of Alzheimer disease. Exp Mol Med 2012;44: 492–502.
   PubMedGoogle Scholar
• Savonenko A, Xu GM, Melnikova T, Morton JL, Gonzales V, Wong MP, et al. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities. Neurobiol Dis 2005;18:602–617.
   PubMed Web of Science ®Google Scholar
• Reiserer RS, Harrison FE, Syverud DC, McDonald MP. Impaired spatial learning in the APPSwe + PSEN1DeltaE9 bigenic mouse model of Alzheimer's disease. Genes Brain Behav 2007;6:54–65.
   PubMed Web of Science ®Google Scholar
• Xiong H, Callaghan D, Wodzinska J, Xu J, Premyslova M, Liu QY, et al. Biochemical and behavioral characterization of the double transgenic mouse model (APPswe/PS1dE9) of Alzheimer's disease. Neurosci Bull 2011;27:221–232.
   PubMed Web of Science ®Google Scholar
• Gong B, Pan Y, Vempati P, Zhao W, Knable L, Ho L, et al. Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated beta-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models. Neurobiol Aging 2013;34:1581–1588.
   PubMed Web of Science ®Google Scholar